iBio's Board proposed an amendment to its 2023 Omnibus Incentive Plan to modify the 'evergreen' provision that automatically increases shares available for issuance, subject to stockholder approval.
iBio's Board proposed an amendment to its 2023 Omnibus Incentive Plan to modify the 'evergreen' provision that automatically increases shares available for issuance, subject to stockholder approval.